To assess the in vivo safety and efficacy of a skin care formulation in terms of reduction in dark spots on healthy female subjects - N/AP

AMVIGOR ORGANICS PVT LTD0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•Indian Female subjects
•Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
•Between 25 and 55 years of age.
•Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.)

•Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
•(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis

发起方

AMVIGOR ORGANICS PVT LTD